Comparison of Age-related macular degeneration Treatments Trials
GPTKB entity
Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:medical_research_study
gptkb:clinical_trial |
| gptkbp:abbreviation |
gptkb:CATT
|
| gptkbp:clinicalTrialPhase |
gptkb:NCT00593450
|
| gptkbp:comparedTreatment |
gptkb:bevacizumab
gptkb:ranibizumab |
| gptkbp:conditionStudied |
gptkb:age-related_macular_degeneration
|
| gptkbp:firstPublished |
2011
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:principalInvestigator |
gptkb:Daniel_F._Martin
|
| gptkbp:publishedIn |
gptkb:New_England_Journal_of_Medicine
|
| gptkbp:result |
safety
visual acuity efficacy |
| gptkbp:sponsor |
gptkb:National_Eye_Institute
|
| gptkbp:startDate |
2008
|
| gptkbp:studyType |
gptkb:clinical_trial
|
| gptkbp:bfsParent |
gptkb:CATT
|
| gptkbp:bfsLayer |
7
|
| http://www.w3.org/2000/01/rdf-schema#label |
Comparison of Age-related macular degeneration Treatments Trials
|